![Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis | Future Medicinal Chemistry Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.12.25/asset/images/medium/figure4.gif)
Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis | Future Medicinal Chemistry
![A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine](https://www.discoverymedicine.com/Jerold-Chun/files/2011/09/discovery_medicine_no_64_volker_brinkmann_figure_1.png)
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
![Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870314004141-gr4.jpg)
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
![Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrd3248/MediaObjects/41573_2010_Article_BFnrd3248_Fig1_HTML.jpg)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
![Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology](https://www.frontiersin.org/files/Articles/213058/fneur-07-00139-HTML/image_m/fneur-07-00139-g001.jpg)
Frontiers | Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke | Neurology
![Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis | Semantic Scholar Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bd79be78de3262ee85d2e6bf6bf6e272cc48c294/3-Figure1-1.png)
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis | Semantic Scholar
![Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0035378718304995-gr1.jpg)
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement - ScienceDirect
![Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870314004141-gr2.jpg)
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
![IJMS | Free Full-Text | Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment | HTML IJMS | Free Full-Text | Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment | HTML](https://www.mdpi.com/ijms/ijms-22-08370/article_deploy/html/images/ijms-22-08370-g004.png)
IJMS | Free Full-Text | Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment | HTML
![Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870314004141-gr1.jpg)
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications - ScienceDirect
![Frontiers | Fingolimod for the treatment of neurological diseases—state of play and future perspectives | Cellular Neuroscience Frontiers | Fingolimod for the treatment of neurological diseases—state of play and future perspectives | Cellular Neuroscience](https://www.frontiersin.org/files/Articles/112957/fncel-08-00283-HTML/image_m/fncel-08-00283-g004.jpg)
Frontiers | Fingolimod for the treatment of neurological diseases—state of play and future perspectives | Cellular Neuroscience
![FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system - Brinkmann - 2009 - British Journal of Pharmacology - Wiley Online Library FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system - Brinkmann - 2009 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/883651e5-3902-468f-9e2c-44ca5481d61b/bph_451_f1.gif)